Yamamoto, Atsushi
Nagao, Michinobu https://orcid.org/0000-0001-6049-8857
Ishigaki, Keiko
Shichiji, Minobu
Kihara, Yuki
Sakai, Akiko
Minami, Yuichiro
Goto, Yasuhiro
Yoneyama, Masami
Sakai, Shuji
Yamaguchi, Junichi
Article History
Received: 7 May 2025
Accepted: 2 July 2025
First Online: 21 July 2025
Declarations
:
: Keiko Ishigaki is in receipt of research grants from Astellas Pharma Inc. (clinical research), Sarepta Therapeutics, Inc. (clinical trial), Taiho Pharmaceutical Company, Limited (clinical trial) and Nippon Shinyaku Co Ltd (clinical trial). Minobu Shichiji and Yuki Kihara are in receipt of research grants from Astellas Pharma Inc. (clinical research).
: The study was conducted in accordance with the principles of the Declaration of Helsinki. The protocol was approved by the Ethics Review Committee of our hospital (approval number: 4036-R). Informed consent was obtained from all patients or their proxies.
: Not applicable.